Cargando…

Chronic myeloid leukemia: Review of our Indian experience

Detalles Bibliográficos
Autor principal:	Bhave, Abhay A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2013
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902610/ https://www.ncbi.nlm.nih.gov/pubmed/24516295 http://dx.doi.org/10.4103/0971-5851.123703

Ejemplares similares

Chronic myeloid leukemia: An Indian scenario
por: Digumarti, Raghunadharao
Publicado: (2016)

Chronic myeloid leukemia versus acute myeloid leukemia in patients with retinoblastoma
por: Leahey, Ann-Marie, et al.
Publicado: (2021)

Chronic myeloid leukemia in India
por: Goldman, John M.
Publicado: (2013)

Tyrosine kinase domain mutations in chronic myelogenous leukemia patients: Indian perspective
por: Ghosh, K
Publicado: (2022)

Chronic myeloid leukemia data from India
por: Bansal, Shweta, et al.
Publicado: (2013)

Specific reversal agents: Fast and fearless – A new era in anticoagulation care
por: Bhave, Abhay
Publicado: (2019)

Changing trends in clinico-morphological profile of chronic myeloid leukemia-our experience
por: Palta, Anshu, et al.
Publicado: (2015)

Current Management of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors
por: Haznedaroğlu, İbrahim C.
Publicado: (2013)

Oncogenic signaling: new insights and controversies from chronic myeloid leukemia
por: Van Etten, Richard A.
Publicado: (2007)

Immune control in chronic myeloid leukemia
por: Ilander, Mette, et al.
Publicado: (2017)

The transformative journey of chronic myeloid leukemia
por: Neelakantan, Pratap, et al.
Publicado: (2018)

Acute myeloid leukemia with 3q26 abnormality: An editorial perspective
por: Ghosh, K
Publicado: (2018)

Breast cancer: Indian experience, data, and evidence
por: Gupta, Sudeep
Publicado: (2016)

Summary of the published Indian data on chronic myeloid leukemia
por: Singhal, Manish K., et al.
Publicado: (2016)

As is our Pathology, So is our Practice
por: Biswas, Jyotirmay
Publicado: (2011)

Imatinib in chronic myeloid leukemia elderly patients
por: Gugliotta, Gabriele, et al.
Publicado: (2011)

Chronic myeloid leukemia in the Imatinib era – Compilation of Indian data from 22 centers involving 8115 patients
por: Parikh, Purvish, et al.
Publicado: (2013)

Initial Rate of BCR::ABL1 Decline for Response Prediction in Chronic Myeloid Leukemia
por: Branford, Susan
Publicado: (2022)

What is treatment free remission in chronic myeloid leukemia?
por: Rea, Delphine, et al.
Publicado: (2017)

Chronic Myeloid Leukemia Prognosis and Therapy: Criticisms and Perspectives
por: Russo, Domenico, et al.
Publicado: (2020)

The emergence of antihistamines as unexpected allies in our fight against acute myeloid leukaemia
por: Winter, Stuart S.
Publicado: (2019)

Long non-coding RNAs emerge as a novel prognostic indicator in pediatric acute myeloid leukemia
por: Velasco-Hernandez, Talia, et al.
Publicado: (2023)

Analysis of adverse drug reactions of imatinib in chronic myeloid leukemia patients: An Eastern Indian experience
por: Swain, Trupti Rekha, et al.
Publicado: (2022)

Day care ophthalmic surgeries at a secondary care hospital in Oman: Our experience
por: Bhatia, Jagdish, et al.
Publicado: (2017)

Rewiring of the Transcription Factor Network in Acute Myeloid Leukemia
por: Assi, Salam A, et al.
Publicado: (2019)

Acute myeloid leukemia: leukemia stem cells write a prognostic signature
por: Gudgin, Emma J, et al.
Publicado: (2011)

Our Eye is on the Future
por: Edward, Deepak P.
Publicado: (2010)

Residual stroke risk in atrial fibrillation: Our patients must be our partners
por: Glotzer, Taya V.
Publicado: (2022)

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia
por: Tiribelli, Mario, et al.
Publicado: (2019)

Clinical Impact of Measurable Residual Disease in Acute Myeloid Leukemia
por: Azenkot, Tali, et al.
Publicado: (2022)

Acute Myeloid Leukemia during the COVID Pandemic: Impact and the Indian Experience
por: Philip, Chepsy C, et al.
Publicado: (2022)

Sushrutha - our proud heritage
por: Bhattacharya, Surajit
Publicado: (2009)

Commentary: Coats disease: Our experience in India
por: Kumar, Atul, et al.
Publicado: (2019)

PPARγ ligands increase antileukemic activity of second- and third-generation tyrosine kinase inhibitors in chronic myeloid leukemia cells
por: Glodkowska-Mrowka, E, et al.
Publicado: (2016)

Chronic myeloid leukemia in children, do we have all the answers?
por: Bansal, Shweta
Publicado: (2014)

Chronic Myeloid Leukemia Data at ASH 2021: A Podcast on Patient Unmet Needs and Later-Line Treatment Developments
por: Breccia, Massimo
Publicado: (2022)

Protein Tyrosine Phosphatase Receptor Gamma as Potential Therapeutic Target for Chronic Myeloid Leukemia Patients
por: Ismail, Mohamed A., et al.
Publicado: (2022)

Thanks to our peer reviewers
Publicado: (2018)

Thanks to our peer reviewers
Publicado: (2017)

Restoring the Long Noncoding RNA MEG3 Indicates a Potential Role for JAK-STAT Signaling in Chronic Myeloid Leukemia
por: Olson, Thomas L., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7fs2hnl314c6l2p8qhpvgsmo1t